Reference health

Differential dopamine release by psychosis-generating and non-psychosis-generating addictive substances in the nucleus accumbens and dorsomedial striatum

https://doi.org/10.1038/s41398-021-01589-z
CiteStamped reference-health badge
75/75 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 75 checked references that resolve
resolves10.1016/S0140-6736(09)60995-8
Schizophrenia
resolves10.1007/s004060070002
Epidemiology of schizophrenia: the global burden of disease and disability
resolves10.1016/j.euroneuro.2005.04.009
Size of burden of schizophrenia and psychotic disorders
resolves10.1016/S0140-6736(13)61611-6
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
resolves10.1016/S0140-6736(04)16458-1
Schizophrenia
resolves10.1093/bmb/ldv017
Antipsychotic medication in schizophrenia: a review
resolves10.1016/j.drugalcdep.2018.07.011
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis
resolves10.1016/0165-0173(94)90012-4
Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula
resolves10.1097/YCO.0000000000000254
Psychosis induced by amphetamines
resolves10.1080/15504263.2014.906133
Cocaine-Induced Psychotic Disorders: Presentation, Mechanism, and Management
resolves10.1146/annurev.ne.19.030196.001535
Addictive Drugs and Brain Stimulation Reward
resolves10.1111/j.1460-9568.2012.07990.x
From prediction error to incentive salience: mesolimbic computation of reward motivation
resolves10.1126/science.2903550
Cellular and Molecular Mechanisms of Drug Dependence
resolves10.1007/s00213-006-0405-4
Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics
resolves10.1093/schbul/sbu026
Amotivation in Schizophrenia: Integrated Assessment With Behavioral, Clinical, and Imaging Measures
resolves10.1002/syn.890210207
Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self‐administration
resolves10.1176/ajp.137.12.1518
Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency
resolves10.1111/j.1600-0773.1963.tb01730.x
Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain
resolves10.1016/S0140-6736(78)90193-9
MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA
resolves10.1073/pnas.97.14.8104
Increased baseline occupancy of D <sub>2</sub> receptors by dopamine in schizophrenia
resolves10.1016/S0006-3223(99)00067-0
Increased dopamine transmission in schizophrenia: relationship to illness phases
resolves10.1073/pnas.93.17.9235
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
resolves10.1176/ajp.155.11.1550
Alterations of Benzodiazepine Receptors in Type II Alcoholic Subjects Measured With SPECT and [<sup>123</sup>I]Iomazenil
resolves10.1093/schbul/sbx180
Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
resolves10.1124/jpet.108.147058
The Smoking Cessation Medication Varenicline Attenuates Alcohol and Nicotine Interactions in the Rat Mesolimbic Dopamine System
resolves10.1073/pnas.85.14.5274
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
resolves10.1016/j.neuropharm.2014.03.010
The involvement of accumbal glycine receptors in the dopamine-elevating effects of addictive drugs
resolves10.1093/alcalc/agu047
Increase in Nucleus Accumbens Dopamine Levels Following Local Ethanol Administration Is Not Mediated by Acetaldehyde
resolves10.1016/j.pbb.2019.172831
Sub-chronic taurine administration induces behavioral sensitization but does not influence ethanol-induced dopamine release in the nucleus accumbens
resolves10.1038/mp.2016.252
Cannabis use and risk of schizophrenia: a Mendelian randomization study
resolves10.1016/j.biopsych.2015.08.001
Association Between Cannabis and Psychosis: Epidemiologic Evidence
resolves10.1176/appi.ajp.2019.18101217
Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample
resolves10.1016/j.neuropharm.2015.06.001
Age-contingent influence over accumbal neurotransmission and the locomotor stimulatory response to acute and repeated administration of nicotine in Wistar rats
resolves10.1002/syn.890160105
Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area
resolves10.1016/S0091-3057(97)00527-3
The Acute Effects of Amphetamine Derivatives on Extracellular Serotonin and Dopamine Levels in Rat Nucleus Accumbens
resolves10.1002/syn.20489
Cocaine‐induced dopamine overflow within the nucleus accumbens measured by in vivo microdialysis: A meta‐analysis
resolves10.1016/0028-3908(91)90145-2
Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats
resolves10.1111/acer.13246
Regional Analysis of the Pharmacological Effects of Acute Ethanol on Extracellular Striatal Dopamine Activity
resolves10.1007/s00213-007-0879-8
Behavioural and neurochemical effects of combined MDMA and THC administration in mice
resolves10.1016/0091-3057(91)90367-B
THC does not affect striatal dopamine release: Microdialysis in freely moving rats
resolves10.1111/j.1471-4159.2008.05503.x
Behavioral sensitization to Δ<sup>9</sup>‐tetrahydrocannabinol and cross‐sensitization with morphine: differential changes in accumbal shell and core dopamine transmission
resolves10.1146/annurev.pharmtox.47.120505.105140
New Insights into the Mechanism of Action of Amphetamines
resolves10.1523/JNEUROSCI.4901-04.2006
Cocaine Increases Dopamine Release by Mobilization of a Synapsin-Dependent Reserve Pool
resolves10.1016/j.celrep.2018.04.062
Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission
resolves10.1097/00001756-199809140-00033
Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area
resolves10.1017/S1461145702003188
Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes
resolves10.1152/jn.00760.2007
Differential Modulation by Nicotine of Substantia Nigra Versus Ventral Tegmental Area Dopamine Neurons
resolves10.1111/acer.13483
The Glycine Receptor—A Functionally Important Primary Brain Target of Ethanol
resolves10.1007/978-3-642-28720-6_170
Neurocircuitry Involved in the Development of Alcohol Addiction: The Dopamine System and its Access Points
resolves10.1523/JNEUROSCI.12-02-00483.1992
Opioids excite dopamine neurons by hyperpolarization of local interneurons
resolves10.1016/j.neuropharm.2004.09.005
Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release
resolves10.1111/j.1476-5381.1992.tb09067.x
The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity
resolves10.4103/0972-6748.119646
Alcoholic hallucinosis
resolves10.1176/ajp.144.10.1340
Antipsychotic effect of buprenorphine in schizophrenia
resolves10.1016/S0140-6736(77)90319-1
ANTIPSYCHOTIC EFFECT OF OPIATE AGONISTS
resolves10.1124/pr.110.002642
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
resolves10.1111/j.1530-0277.2009.00942.x
Disparity Between Tonic and Phasic Ethanol‐Induced Dopamine Increases in the Nucleus Accumbens of Rats
resolves10.1002/syn.10226
Alcohol promotes dopamine release in the human nucleus accumbens
resolves10.1007/s00213-014-3720-1
Beer self-administration provokes lateralized nucleus accumbens dopamine release in male heavy drinkers
resolves10.1038/jcbfm.2014.209
Intravenous Ethanol Increases Dopamine Release in the Ventral Striatum in Humans: PET Study Using Bolus-Plus-Infusion Administration of [ <sup>11</sup> C]raclopride
resolves10.1016/j.drugalcdep.2016.01.001
Differences in IV alcohol-induced dopamine release in the ventral striatum of social drinkers and nontreatment-seeking alcoholics
resolves10.1038/mp.2010.56
A genetic determinant of the striatal dopamine response to alcohol in men
resolves10.1038/npp.2008.87
Ventral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette
resolves10.1176/appi.ajp.161.7.1211
Smoking-Induced Ventral Striatum Dopamine Release
resolves10.1017/S1461145707008103
Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study
resolves10.1093/ntr/nts029
Denicotinized Versus Average Nicotine Tobacco Cigarette Smoking Differentially Releases Striatal Dopamine
resolves10.1523/JNEUROSCI.3661-14.2014
Sex Differences in the Brain's Dopamine Signature of Cigarette Smoking
resolves10.1002/syn.20419
The effect of nicotine on striatal dopamine release in man: A [<sup>11</sup>C]raclopride PET study
resolves10.1016/j.biopsych.2019.03.965
Striatal Dopamine Release in Response to Morphine: A [11C]Raclopride Positron Emission Tomography Study in Healthy Men
resolves10.1192/bjp.bp.107.041228
Brain dopamine response in human opioid addiction
resolves10.1111/adb.12073
Investigating expectation and reward in human opioid addiction with [ <sup>11</sup> <scp>C</scp> ]raclopride <scp>PET</scp>
resolves10.1016/j.neuroimage.2009.06.029
Can recreational doses of THC produce significant dopamine release in the human striatum?
resolves10.1016/j.neuroimage.2010.04.274
Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge
resolves10.1007/s00213-015-3915-0
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
resolves10.1371/journal.pone.0070378
Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography Study
The 1 reference without a DOI — listed, not checked
no DOI — not checkedPaxinos G. The rat brain in stereotaxic coordinates. 6. ed. ed. Amsterdam [u.a.]: Amsterdam u.a. : Elsevier, Academic Press; 2007. .
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1038/s41398-021-01589-z"><img src="https://citestamp.com/citestamped/10.1038/s41398-021-01589-z/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1038/s41398-021-01589-z/badge.svg)](https://citestamp.com/citestamped/10.1038/s41398-021-01589-z)